Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,342.80 -159.96 -1.28%
S&P 500 1,298.15 -18.48 -1.40%
Nasdaq 2,805.12 -33.96 -1.20%
Ticker Volume Price Price Delta
STOXX 50 2,134.05 -58.80 -2.68%
FTSE 100 5,266.41 -136.87 -2.53%
DAX 6,285.75 -149.85 -2.33%
Ticker Volume Price Price Delta
Nikkei 8,556.60 -172.69 -1.98%
TOPIX 721.57 -11.76 -1.60%
Hang Seng 18,786.20 -252.96 -1.33%
Gold 1,539.10 -2.38%
EUR-USD 1.2565 -0.9398%
Nasdaq 2,805.12 -1.20%
DJIA 12,342.80 -1.28%
S&P 500 1,298.15 -1.40%
FTSE 100 5,266.41 -2.53%
STOXX 50 2,134.05 -2.68%
DAX 6,285.75 -2.33%
Oil (WTI) 89.88 -2.14%
U.S. 10-year 1.712% -0.057
BAC:US 6.89 -1.36%
8306:JP 339.00 -0.88%

CCLA's Bevan Recommends Apple, Amgen and Novo Nordisk: Video

2010-03-15T10:09:06Z
CCLA's Bevan Recommends Apple, Amgen and Novo Nordisk
 
Play Video

March 15 (Bloomberg) -- James Bevan, chief investment officer at CCLA Investment Management, talks about his equities strategy. Bevan, who oversees $10 billion, speaks with Bloomberg's Rishaad Salamat in London. (Source: Bloomberg)

James Bevan, chief investment officer at CCLA Investment Management, talks about his equities strategy.

Bevan, who oversees $10 billion, speaks with Bloomberg's Rishaad Salamat in London. (Source: Bloomberg) 

00:00 Outlook for equities, stock recommendations
01:08 U.K. economic recovery, impact of pound
02:56 U.S. corporate earnings, housing market

Running time 04:25

Sponsored Links
Advertisement
Sponsored Links
Advertisement
Advertisements